Amniotic Membrane Market by Product (Cryopreserved Amniotic Membrane, Lyophilization Amniotic Membrane), Application (Ophthalmology, Surgical Wound), End User - Global Forecast 2024-2030

Amniotic Membrane Market by Product (Cryopreserved Amniotic Membrane, Lyophilization Amniotic Membrane), Application (Ophthalmology, Surgical Wound), End User - Global Forecast 2024-2030

The Amniotic Membrane Market size was estimated at USD 1.02 billion in 2023 and expected to reach USD 1.13 billion in 2024, at a CAGR 9.26% to reach USD 1.90 billion by 2030.

The amniotic membrane market encompasses producing, distributing, and selling amniotic membranes for various medical applications. Amniotic membranes, derived from the innermost layer of the placenta and contain a unique combination of cells and extracellular matrix, have regenerative properties used in various therapeutic practices, especially in ophthalmology, wound care, and surgical procedures. Amniotic membranes are utilized in various medical applications due to their anti-inflammatory, anti-fibrotic, and anti-microbial properties and their ability to support stem cell proliferation. Nonetheless, the growth of the amniotic membrane market faces several limitations and challenging factors, such as ethical constraints, regulation, and cost constraints. Advances in preservation technologies, such as cryopreservation and dehydrated products, are making storing and transporting these membranes easier, thus expanding their availability and shelf-life. Ongoing research is discovering new therapeutic applications for the amniotic membrane, opening up further markets. Increased awareness among healthcare professionals and patients about the benefits of amniotic membrane-based products is also creating opportunities for market expansion.

Regional Insights

The amniotic membrane market in the Americas is experiencing substantial growth, driven by a strong presence of sophisticated healthcare infrastructure, heightened awareness amongst both practitioners and patients, and favorable reimbursement policies. The United States stands out as the primary market due to its well-established healthcare system and the presence of key players in the regenerative medicine sector. In the EMEA region, demand for amniotic membranes is growing, driven by increased adoption in ophthalmology and wound care. The European market is particularly robust, supported by stringent EU regulations that ensure product quality and safety. The rise in chronic diseases and an aging population contribute to this heightened demand. The Middle East exhibits growth potential with increased investments in healthcare infrastructure, though market penetration is still in its nascent stages compared to Europe. In Africa, the market is relatively underdeveloped, faced with challenges such as limited healthcare facilities and lower awareness levels, but it holds potential for future growth due to a gradual improvement in healthcare systems. The APAC region is anticipated to be the fastest-growing market for amniotic membranes, thanks to rapidly advancing healthcare infrastructure, increasing investments in regenerative medicine, and an expansive patient population. Countries like China, Japan, and India are leading this growth trajectory.

Market Insights

• Market Dynamics
  
  The market dynamics represent an ever-changing landscape of the Amniotic Membrane Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
  • Market Drivers
    • Demand for amniotic membrane transplantations
    • Rising the geriatric population around the world
    • Growing incidence of accident and trauma cases
    • Market Restraints
      • Lack of skilled professionals in healthcare sector
      • Market Opportunities
        • Increasing R&D activities in the amniotic membrane for regenerative medicine and stem cell biology
        • Growing awareness of amniotic membrane benefits and birth tissue donations
        • Market Challenges
          • Maintaining sufficient storage temperature level
          • Market Segmentation Analysis
            • Product: Increase in use of cryopreserved amniotic membranes live cell therapy
            • Application: Employment of amniotic membrane in ophthalmology treating complex ocular surface diseases
            • End User: Significant use products across Hospitals for surgical procedures
            • Market Disruption Analysis
            • Porter’s Five Forces Analysis
            • Value Chain & Critical Path Analysis
            • Pricing Analysis
            • Technology Analysis
            • Patent Analysis
            • Trade Analysis
            • Regulatory Framework Analysis
            FPNV Positioning Matrix
            
            The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Amniotic Membrane Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
            
            Market Share Analysis
            
            The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Amniotic Membrane Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
            
            Recent Developments
            • NovaBay to commercialize Amniotic Tissue Allograft as Avenova Allograft
              
              NovaBay Pharmaceuticals, Inc., developing innovative products for large unmet therapeutic needs, has secured commercial rights to a promising Amniotic Tissue Allograft from BioStem Technologies, Inc., a pioneering regenerative biotechnology company based in Florida. Specializing in the production of perinatal tissue-based allografts, BioStem Technologies leverages the innate healing capabilities of amniotic material to address a spectrum of degenerative conditions with the potential for restorative outcomes. This strategic partnership marks a significant advance in NovaBay Pharmaceuticals' commitment to expanding its portfolio with groundbreaking regenerative therapies, thus enhancing its role in the dynamic landscape of biotechnological healthcare solutions.
              
              Coloplast announces agreement to acquire Kerecis and raises long-term growth expectations
              
              Coloplast acquired Kerecis, a pioneering force in the biologics wound care market, for a substantial sum, potentially reaching USD 1.3 billion. Coloplast will provide an upfront payment of USD 1.2 billion, significantly enhancing its footprint in the advanced wound care sector. Kerecis, recognized for its innovative and patented fish skin technology platform, has carved out a niche in the United States wound care market, demonstrating substantial growth. This acquisition represents Coloplast's commitment to improving treatment options within the wound healing domain while diversifying its product portfolio and capitalizing on emerging trends in biological treatments. This move is poised to deliver both companies a competitive edge, addressing the crucial needs of the advanced wound care segment and offering solutions designed for better patient outcomes.
            Strategy Analysis & Recommendation
            
            The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Amniotic Membrane Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
            
            Key Company Profiles
            
            The report delves into recent significant developments in the Amniotic Membrane Market, highlighting leading vendors and their innovative profiles. These include Applied Biologics, LLC, BioStem Technologies, Inc., BioTissue Holdings, Inc., Celularity Inc., FzioMed Inc., Genesis Biologics Inc., Integra LifeSciences Holdings Corporation, Katena Products, Inc., Laboratoire CCD, Lucina BioSciences, LLC, Merakris Therapeutics, MiMedx Group, Inc., Next Biosciences (Pty) Limited, NuVision Biotherapies Ltd, Organogenesis Holdings Inc., PuraGraft, Seed Biotech, Inc., Skye Biologics Holdings, LLC, Smith & Nephew PLC, Stryker Corporation, Surgenex, LLC, Surgilogix, The Electrospinning Company, Thea Pharma Inc., Ventris Medical, LLC, and VIVEX Biologics, Inc..
            
            Market Segmentation & Coverage
            
            This research report categorizes the Amniotic Membrane Market to forecast the revenues and analyze trends in each of the following sub-markets:
            • Product
              • Cryopreserved Amniotic Membrane
              • Lyophilization Amniotic Membrane
              • Application
                • Ophthalmology
                • Surgical Wound
                • End User
                  • Ambulatory Surgical Center
                  • Hospital
                  • Research Centers Laboratory
                  • Specialized Clinic
                  • Region
                    • Americas
                      • Argentina
                      • Brazil
                      • Canada
                      • Mexico
                      • United States
                        • California
                        • Florida
                        • Illinois
                        • New York
                        • Ohio
                        • Pennsylvania
                        • Texas
                        • Asia-Pacific
                          • Australia
                          • China
                          • India
                          • Indonesia
                          • Japan
                          • Malaysia
                          • Philippines
                          • Singapore
                          • South Korea
                          • Taiwan
                          • Thailand
                          • Vietnam
                          • Europe, Middle East & Africa
                            • Denmark
                            • Egypt
                            • Finland
                            • France
                            • Germany
                            • Israel
                            • Italy
                            • Netherlands
                            • Nigeria
                            • Norway
                            • Poland
                            • Qatar
                            • Russia
                            • Saudi Arabia
                            • South Africa
                            • Spain
                            • Sweden
                            • Switzerland
                            • Turkey
                            • United Arab Emirates
                            • United Kingdom
                            
                            
                            Please Note: PDF & Excel + Online Access - 1 Year